Iihormone azihlali zihleli. Ukususela kumjikelo wokuqala wokuya exesheni kwiminyaka yobutsha ukuya kutshintsho lweehormone zokuya exesheni emva kwamashumi eminyaka, umzimba womfazi uhlala uhlengahlengisa amanqanaba atshintshayo e-estrogen, i-progesterone, kunye nezinye iihormone. Isigaba ngasinye sobomi sinenguqulelo yaso "yesiqhelo," kunye nesethi yaso yemingeni.
Iminyaka Yokuzala: Isingqisho Senyanga
Ngexesha lokuzala, umzimba womfazi usebenza kumjikelo weehomoni othatha malunga nenyanga: i-estrogen iyanda kwisiqingatha sokuqala ukulungiselela umzimba ukukhulelwa okunokwenzeka, emva koko i-progesterone ithatha indawo emva kokukhutshwa kweqanda. Xa olu tshintsho luphazamiseka, nokuba ziimpawu zemihla ngemihla zangaphambi kokuya exesheni okanye ukungalingani okukhulu kweehomoni njenge-polycystic ovary syndrome (PCOS), imiphumo ekuhambeni rhoqo komjikelo, ulusu, kunye nentuthuzelo yemihla ngemihla inokuba nkulu.
Ixesha lokuya exesheni kunye nokuya exesheni: Isiseko sokutshintsha
Ixesha lokutshintsha ngaphambi kokuba ixesha lokuya exesheni liphele ngokupheleleyo, lidla ngokuqala xa umfazi eneminyaka engama-40 ubudala. Amanqanaba e-estrogen kunye ne-progesterone awanciphisi rhoqo ngeli nqanaba, ayatshintshatshintsha, ngamanye amaxesha kakhulu, nto leyo eyenza ukuba ixesha lokuya exesheni, ubuthongo, kunye neemvakalelo zibonakale zingaqinisekanga ngeli xesha. Ukuya exesheni ngokwako kufikwa emva kweenyanga ezilishumi elinambini ezilandelelanayo ngaphandle kwexesha, nto leyo ephawula isigaba esizinzileyo nesiphantsi se-estrogen, nangona utshintsho lokuya apho ludla ngokuba lolona lubangela iimpawu ezibonakalayo: ubushushu, ukubila ebusuku, kunye nokulala okuphazamisekayo.
Oko Kuthethwa Luphando Lwezityalo
Kuye kwafundwa inani leemveliso zezityalo ngendima yazo ekuxhaseni abafazi ngezi nguqu zeehomoni. Umzekelo, i-Ashwagandha ( Withania somnifera ) ivavanyiwe ngokukodwa kubasetyhini abakwixesha lokuya exesheni: kuvavanyo lweeveki ezisibhozo lwabasetyhini abali-100, abo bathatha i-300 mg ye-ashwagandha root extract kabini ngemini babone ukuphucuka okukhulu kakhulu kumanqaku eempawu zokuya exesheni kuneqela le-placebo, kunye nokunyuka okulinganiselweyo kwi-estradiol kunye nokwehla kwe-FSH kunye ne-LH (Gopal et al., 2021). I-Shatavari ( Asparagus racemosus ), okwangoku, inembali ende kumayeza e-Ayurvedic anxulunyaniswa ngqo nempilo yabasetyhini, ngenxa yee-steroidal saponins kwiingcambu zayo ezifundwayo ngomsebenzi othambileyo, ofana ne-phytoestrogen. Zombini zizityalo eziveliswa yi-NaturMed Scientific ngendlela emiselweyo.
USerebelle: Oko Kuboniswa Yidatha Yeklinikhi
I-Serebelle yi-NaturMed Scientific's standardized Shatavari root extract, kwaye ngokungafaniyo nezinye izithako ezininzi zezityalo kweli candelo, ivavanyiwe kwiimvavanyo ezimbini ezahlukeneyo, ezibhalisiweyo, ezingacwangciswanga, ezingaboni kabini, ezilawulwa yi-placebo, nganye ijolise kwinqanaba lobomi elahlukileyo.
Kwabasetyhini abaneminyaka engama-20-35 ubudala abanokungalingani kweehomoni okunxulumene ne-PCOS (n=60, iintsuku ezingama-84), uSerebelle wenze umahluko omkhulu xa kuthelekiswa ne-placebo. Umthamo we-ovarian wehle nge-21%, ubungakanani be-cyst bancipha nge-41%, kwaye inani le-follicle lehla nge-21% (p<0.0001). Ekupheleni kovavanyo, ama-62% abasetyhini abasebenzisa iSerebelle babenomthamo we-ovarian ubuyele kwinqanaba elisempilweni, xa kuthelekiswa ne-7% kuphela kwi-placebo. Uvakalelo lwe-insulin luphucukile, amanqanaba e-testosterone ehla, kwaye i-hormone ebizwa ngokuba yi-SHBG inyukile, konke kubhetele kune-placebo. Amanqaku e-Hirsutism kunye ne-acne nawo aphucukile (Kondamudi et al., 2025).
Kwabasetyhini abakwiminyaka engama-40-50 ubudala (n=75, iintsuku ezili-120), zombini iidosi zemihla ngemihla ze-50 mg kunye ne-100 mg zeSerebelle zinciphise amanqaku eempawu zokuya exesheni ngama-51-73%, xa kuthelekiswa nokuphucuka kwe-placebo ngama-23% kuphela (p<0.001). Ubushushu bunciphe ukuya kuthi ga kwi-40% kwidosi ephezulu, ngelixa busiba mandundu kancinci kwiqela le-placebo. I-FSH, i-hormone enyukayo njengoko i-menopause isondela, yehla ukuya kuthi ga kwi-61%, kwaye i-LH yehla ukuya kuthi ga kwi-43%. I-AMH, uphawu lwe-ovarian reserve, inyuke ukuya kuthi ga kwi-270% kwidosi ephezulu. Zonke ezi nguqu bezingcono kakhulu kunesiqalo kunye ne-placebo (p<0.001) (Yadav et al., 2025).
Kuzo zombini ezi zilingo, iSerebelle yanyamezela kakuhle, kungekho ziganeko zimbi zibikiweyo. Zombini ezi zifundo zixhaswe yiChemiloids Life Sciences, nto leyo ekufanele iqatshelwe ukuze icace; ukuphindaphindwa ngokuzimeleyo kuya kongeza ukuzithemba kwezi ziphumo.
Iingcango ezimbalwa ezithembekileyo
Uphando lwezityalo kweli candelo lusakhula. Iimpawu zehomoni zinokudibana nezinye iimeko zempilo, ezifana neengxaki ze-thyroid, ngoko ke nabani na ofumana iimpawu ezibalulekileyo okanye ezingapheliyo kufuneka athethe nomboneleli wezempilo ngaphambi kokuba aqalise nasiphi na isongezelelo esitsha, ingakumbi ngexesha lokukhulelwa okanye ngexesha lokuncancisa. Okuboniswa luphando ukuza kuthi ga ngoku kuyakhuthaza ngokwenene, kodwa kufuneka kufundwe njengenxalenye yendlela ebanzi, eyenzelwe wena buqu impilo yabasetyhini.
Qaphela: Izithako ekuxoxwe ngazo kweli nqaku zizithako zezongezo zokutya, azizo iimveliso zamayeza ezinelayisenisi, kwaye azijoliswanga ekuxilongeni, ekunyangeni, ekunyangeni, okanye ekuthinteleni nasiphi na isifo. Abathengi abaneengxaki zempilo esele zikhona okanye abo bathatha amayeza bayacetyiswa ukuba badibane neengcali zempilo ezifanelekileyo ngaphambi kokuba basebenzise.
Ucaphulo
Gopal, S., Ajgaonkar, A., Kanchi, P., Kaundinya, A., Thakare, V., Chauhan, S. kunye noLangade, D. (2021) 'Isiphumo se-ashwagandha (Withania somnifera) ingcambu yesicatshulwa kwiimpawu ze-climacteric kubasetyhini ngexesha le-perimenopause: uphando olucwangcisiweyo, olungaboni kabini, olulawulwa yi-placebo', iJenali yoPhando lwe-Obstetrics and Gynaecology, 47(12), iphe. 4414–4425. Ifumaneka apha: https://doi.org/10.1111/jog.15030
UKendamudi, S., uSadu, S., uDeva, S., uYalamanchi, A. kunye noYalamanchi, A. (2025) 'CL22209, isicatshulwa seengcambu ze-Asparagus racemosus esisemgangathweni, sibonisa ukuphuculwa kokwakheka kwe-ovarian, ukulungelelana kokuya esikhathini, kunye neeparameter ze-metabolic kubasetyhini abane-polycystic ovary syndrome kuvavanyo olucwangcisiweyo nolulawulwayo', uPhando lwezoKutya kunye neZondlo, 69, inqaku 13244. Ifumaneka apha: https://doi.org/10.29219/fnr.v69.13244
Yadav, P., Yadav, S., Vedururu, SS kunye noKumari, G. (2025) 'Uvavanyo lweklinikhi lwe-CL22209, isicatshulwa esisemgangathweni se-Asparagus racemosus, sokunciphisa iimpawu ze-vasomotor kunye neempawu zokuya esikhathini kubasetyhini abakwi-perimenopausal: uphando olucwangcisiweyo, olungaboni kabini, olulawulwa yi-placebo', Functional Foods in Health and Disease, 15(7), iphe. 415–443. Ifumaneka apha: https://doi.org/10.31989/ffhd.v15i7.1684
Isikhanyeli: Le ngxelo ayikhange ihlolwe yi-EFSA, i-KFDA okanye i-FDA. Le mveliso ayenzelwanga ukuxilonga, ukunyanga, ukunyanga, okanye ukuthintela nasiphi na isifo. Nangona ulwazi olunikiweyo lusekelwe kwiingxelo ezithembekileyo, asenzi naziphi na izibango okanye iziqinisekiso ezithile. Kubalulekile ukubonisana nomcebisi wakho wezempilo ukuze ufumane iingcebiso kunye nesikhokelo esihambelana nempilo yakho.
